Skip to content

Effect of Electrical Muscle Stimulation in Critically Ill Patients

The Effects of Electrical Muscle Stimulation (EMS) on Muscle Atrophy and Functional Outcomes in Critically Ill Patients; a Pilot Randomized Controlled Trial

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01637467
Enrollment
30
Registered
2012-07-11
Start date
2012-07-31
Completion date
2015-10-31
Last updated
2016-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Keywords

critical illness, myopathy, electrical muscle stimulation

Brief summary

Electrical muscle stimulation (EMS) is the therapy used to passively activate muscles using electrodes on the surface of the skin. EMS may be helpful in preserving muscle function in people who are on bedrest due to critical illness in the intensive care unit. The purpose of this study is to determine the safety and feasibility of implementing EMS in critically ill patients who are on mechanical ventilation for greater than 7 days, and examine the effects of 4 weeks of EMS on leg muscle size, muscle strength and functional outcomes in these patients. The investigators hypothesize that EMS will be safe and feasible and that critically ill patients receiving EMS will show a smaller loss of muscle size and strength than those in the control group, who do not receive EMS.

Interventions

EMS delivered to the quadriceps and gluteal muscles, twice daily, 30 minutes per session for up to 4 weeks.

OTHERSham EMS

Sham EMS delivered to the quadriceps and gluteal muscles, twice daily, 30 minutes per session for up to 4 weeks.

Sponsors

The Lung Association
CollaboratorUNKNOWN
University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* admitted to the medical-surgical ICU or cardiovascular ICU * walking independently prior to admission * mechanically ventilated for more than 7 days (i.e. prolonged ventilation) * receiving enteral or parenteral nutrition.

Exclusion criteria

* history of neurological or psychiatric disease * primary muscle disease (e.g. muscular dystrophy, polymyositis) * catastrophic neurological event * receiving palliative care * contraindications to EMS (e.g. cardiac pacemaker/defibrillator, pregnancy, infected or cancerous lesions in proximity of electrode sites) * inadequate access to electrode sites due to medical devices * lower extremity edema affecting the thighs or buttocks * BMI \> 35 kg/m2 * allergies to adhesives or latex

Design outcomes

Primary

MeasureTime frameDescription
feasibility of EMS treatment4 weeksthe number of EMS treatments that are successfully applied will be expressed as a frequency of the total number of treatments attempted

Secondary

MeasureTime frameDescription
muscle strengthbaseline, 2 weeks and 4 weeksmuscle strength using manual muscle testing
muscle thicknessbaseline, 2 weeks, 4 weeksthickness of the quadriceps muscle will be assessed using muscle ultrasound

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026